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REVIEW 
Heme is a ubiquitous cofactor essential for most 
organisms. The human pathogens Toxoplasma 
gondii and Plasmodium spp. can salvage heme 
or its intermediates from their host, but largely 
rely on its de novo synthesis utilizing an unusual 
heme synthesis pathway, which spans across 
three subcellular compartments. This review 
discusses our understanding of heme 
acquisition in apicomplexans, its role in 
metabolism, and in the activation of the 
antimalarial drug artemisinin (ART). 
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The Apicomplexa phylum groups important human and animal pathogens 
that cause severe diseases, encompassing malaria, toxoplasmosis and 
cryptosporidiosis. In common with most organisms, apicomplexans rely 
on heme as co-factor for several enzymes, including cytochromes of the 
electron transport chain. This heme derives from de novo synthesis 
and/or the development of uptake mechanisms to scavenge heme from 
their host. Recent studies have revealed that heme synthesis is essential 
for Toxoplasma gondii tachyzoites, as well as for the mosquito and liver 
stages of Plasmodium spp. In contrast, the erythrocytic stages of the 
malaria parasites rely on scavenging heme from the host red blood cell. 
The unusual heme synthesis pathway in Apicomplexa spans three 
cellular compartments and comprises enzymes of distinct ancestral 
origin, providing promising drug targets. Remarkably given the 
requirement for heme, T. gondii can tolerate the loss of several heme 
synthesis enzymes at a high fitness cost, while the ferrochelatase is 
essential for survival. These findings indicate that T. gondii is capable of 
salvaging heme precursors from its host. Furthermore, heme is implicated 
in the activation of the key antimalarial drug artemisinin. Recent findings 
established that a reduction in heme availability corresponds to 
decreased sensitivity to artemisinin in T. gondii and Plasmodium 
falciparum, providing insights into the possible development of 
combination therapies to tackle apicomplexan parasites. This review 
describes the microeconomics of heme in Apicomplexa; from supply, 
either from de novo synthesis or scavenging, to demand by metabolic 
pathways, including the electron transport chain.   
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Introduction  
Heme is a ubiquitous, complex organic molecule, 
essential to nearly all organisms across the three 
branches of life (Archaea, Bacteria and Eukarya). It 
belongs to the class of tetrapyrroles, including 
porphin, the simplest tetrapyrrole, porphyrins such 
as heme, chlorins including chlorophylls and corrins 
such as cobalamin (vitamin B12) (Figure 1) [1]. 
Tetrapyrroles are often chromophores due to their 
high degree of conjugation, e.g. chlorophyll grants 
the green color to leaves and heme which colors 
blood red. Tetrapyrroles typically conjugate a metal 
ion in their center. In the case of heme, iron is 
coordinated by four nitrogen atoms of the porphyrin 
ring and can alternate between a reduced and 
oxidized state, enabling the redox and electron 
transfer reactions of heme. This flexibility makes 
heme an essential cofactor for many enzymes; 
famously it enables the binding and transport of 
oxygen in hemoglobin. Additionally, heme is the 
functional group in the antioxidant function of 
peroxidases and catalases, as well as the electron 
transfer reactions of cytochromes in the 
mitochondrial respiratory chain [2]. Besides its role 
as a crucial cofactor, heme is also vital for the 
regulation of iron homeostasis and serves as a 
signaling molecule [3-5]. These diverse, essential 
functions imply that most organisms must acquire 
heme from their environment or synthesize it de 
novo. 
 
The Apicomplexa phylum comprises obligate, 
intracellular parasites which are highly evolutionary 
divergent from model eukaryotes. Members of this 
phylum have developed innovative strategies for 
metabolite synthesis and uptake, including for heme, 
across their complex lifecycles. Many apicomplexan 
parasites are medically relevant pathogens, 
including Toxoplasma gondii, which infects 
approximately one third of the human population [6], 
Plasmodium spp. which currently cause close to 
500,000 deaths per year [7] and Cryptosporidium, 
one of the main causes of deaths in children under 5 
years of age [8]. Several recent studies have probed 
the importance of heme synthesis in T. gondii [9-11] 
and Plasmodium spp. [12-15] and have shed light on 
its role in the activation of artemisinin (ART) [16-18]. 
Given the importance of heme in the biology and 
treatment of these pathogens, we aim to provide an 
overview over of the recent findings in the field, with 
a focus on the heme synthesis pathway in 
apicomplexan parasites.  
 
 
Heme demand in protozoan parasites 
Among the Apicomplexa, the requirement for heme 
varies drastically between species. These 
differences likely reflect the various niches the 
parasites occupy throughout their lifecycles. 
Apicomplexans frequently infect multiple host 
species and undergo both sexual and asexual 
replication. In order to survive in these often 
dramatically different environments, parasites must 
have the flexibility to metabolically adapt [19-21]. 
Underlining this, T. gondii encodes 13 cytochromes, 
as well as a catalase, that depend on heme as a 
cofactor, indicating a relatively high demand for 
heme [22, 23]. Plasmodium falciparum expresses 8 
Fig. 1. The structure and origin of porphins and their 
derivatives. Porphins are a group of molecules consisting of 
four pyrrole rings, including porphyrins, chlorins and corrins. 
The former is the precursor of heme, an essential cofactor for 
nearly all cells and can be synthesized by many different 
organisms, including bacteria, archaea and eukaryotes 
(including plants, fungi, animals, protists). While most 
mammalian cells can produce heme, synthesis largely occurs 
in developing erythroid cells in the bone marrow and in the 
liver. Chlorophyll, a derivative of chlorins, is synthesized in the 
plastids of photosynthetic organism including plants and 
shares much of its synthesis pathway with that of heme. 
Corrins are the precursor of cobalamin or vitamin B12, an 
essential vitamin for humans. Cobalamin is synthesized by 
some bacteria and archaea, including Pseudomonas 
dentrificans and Salmonella typhimurium via an aerobic or 
anaerobic synthesis pathway.  
J. Kloehn, C. R. Harding and D. Soldati-Favre  Heme in Apicomplexa 
 4 
cytochromes and no heme-dependent catalase [22, 
23]. While in contrast, Cryptosporidium parvum lacks 
a conventional mitochondrion and only expresses a 
single heme-containing enzyme of unknown 
function, likely indicating a very low requirement for 
heme in these parasites [22-25]. As proteins of the 
electron transport chain (ETC) are the largest 
destination for heme within these organisms [22, 23], 
changes to the mechanisms of energy generation 
are expected to have large impacts on the heme 
requirements for the Apicomplexa.   
 
The coccididan parasite T. gondii undergoes 
asexual replication in its intermediate hosts in two 
distinct stages: the fast growing tachyzoites which 
are responsible for severe symptomatic disease in 
susceptible hosts  [26-28], and the slow growing, 
encysted bradyzoites which persist for the lifetime of 
their host [29]. Tachyzoites and bradyzoites differ 
not only in their growth rate, but also in their 
metabolism [30-32]. The former rely on the 
mitochondrial respiratory chain for over 90% of their 
adenosine triphosphate (ATP) production through 
oxidative phosphorylation (OXPHOS) [33]. In 
bradyzoites however, OXPHOS is largely inactive 
and ATP is instead predominantly generated 
through glycolysis, which does not require heme-
containing enzymes [34-36]. In fact, reduced activity 
of the respiratory chain has been suggested to be 
one of the factors involved in tachyzoite-to-
bradyzoite conversion [37]. Beyond ATP production 
through OXPHOS, conversion of the saturated fatty 
acid stearate (C18:0) to the monounsaturated oleate 
(C18:1) is also heme dependent. This desaturation 
reaction relies on the stearoyl-coenzyme A (CoA) 
desaturase, cytochrome b5 and the nicotinamide 
adenine dinucleotide phosphate (NADPH) 
cytochrome b5-reductase. Interestingly, all 3 genes 
are expected to be fitness-conferring based on a 
genome-wide Clustered Regularly Interspaced 
Short Palindromic Repeats (CRISPR) fitness screen 
[38], although a recent study suggested 
dispensability of stearoyl-CoA desaturase in T. 
gondii tachyzoites in vitro and in mice [39]. While the 
fatty acid elongation pathway is presumably 
essential in tachyzoites [40], T. gondii has shown 
remarkable capacity to compensate for defects in 
fatty acid synthesis through increased salvage [10, 
40]. A recent study revealed that T. gondii 
bradyzoites efficiently salvage oleate and store 
excess of it in lipid droplets [41], suggesting that 
stearoyl-CoA desaturase might be dispensable at 
this stage. Given the reduced replication rate, and 
reduced activity of the heme-dependent oleate 
synthesis and OXPHOS, it is likely that bradyzoites 
have a reduced requirement for heme compared to 
tachyzoites. T. gondii undergoes sexual 
reproduction inside felids. Due to the very limited 
accessibility of these life cycle stages, little is known 
about their metabolism. Demand for heme in sexual 
stages will depend on how these stages generate 
energy as well as on the availability of heme in the 
cat gut environment. Recent, elegant studies 
suggest that these stages may become more 
tractable in the future [42, 43], opening the possibility 
for these questions to be addressed.  
 
The requirement for heme also varies across the life 
cycle of Plasmodium spp. Asexual, blood-stage 
Plasmodium have unlimited access to glucose and 
were shown to rely mainly on glycolysis to generate 
ATP, while secreting excess lactate through a 
formate/nitrite transporter as a partially oxidized end 
product [44-46]. This dependence on glycolysis for 
energy production may cause a reduced demand for 
heme in blood stage parasites. Nevertheless, the 
mitochondrial ETC, including heme-containing 
cytochromes, is essential for Plasmodium blood 
stage parasites [47]. The dihydroorotate 
dehydrogenase (DHODH), an enzyme of the 
essential pyrimidine biosynthesis pathway, relies on 
ubiquinone-mediated re-oxidation in the inner 
mitochondrial membrane [48-50]. Furthermore, 
chemical inhibition of heme-dependent stearoyl-CoA 
desaturase arrested the growth of intraerythrocytic 
P. falciparum, indicating that heme-dependent 
oleate synthesis is likely active and essential in 
these stages [51]. Optimal efficacy was observed in 
schizonts which exhibit a high demand for 
membrane synthesis [51], while the role of stearoyl-
CoA desaturase in liver and mosquito stages 
remains unclear. Blood stage parasites differentiate 
into gametocytes which are also dependent on 
glycolysis for energy production, suggesting a minor 
role for mitochondrial respiration and possibly a 
similarly reduced requirement for heme [45]. Once 
inside the mosquito, transcriptomic and proteomic 
analyses have revealed upregulation of tricarboxylic 
acid (TCA) cycle enzymes and the ETC, indicating 
an increased reliance on mitochondrial metabolism, 
likely accompanied by a higher demand for heme 
[52].  
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This was experimentally confirmed by tracking the 
development of mutant parasites lacking succinate 
dehydrogenase (a component of complex II) or a 
subunit of the mitochondrial ATP synthase (complex 
V), revealing that mitochondrial respiration is 
essential for the formation of oocysts and 
sporozoites within the vector [46, 53]. Similarly, in 
liver stage Plasmodium yoelii, enzymes of the TCA 
cycle and ETC are overexpressed at the transcript 
and protein levels compared to blood stage 
parasites, indicating an increased reliance on 
OXPHOS for energy production [54]. Indeed, a 
genome-wide screen revealed that components of 
the respiratory chain, including a subunit of the 
mitochondrial ATP synthase and the flavoprotein 
subunit of complex II, are essential for liver stage 
metabolism [55]. 
  
In summary, Plasmodium blood stages depend on 
heme for metabolic processes, including pyrimidine 
and oleate biosynthesis. However, mosquito and 
liver stage parasites rely increasingly on 
mitochondrial metabolism, probably leading to a 
higher demand for heme compared to blood stage 
Plasmodium, which ironically reside in an extremely 
heme-rich environment. Figure 2 highlights the 
fitness score of different heme-containing proteins in 
P. falciparum, P. berghei and T. gondii based on the 
data from recent genome wide CRISPR fitness  
 
 
screens [10, 38, 55-57]. The Plasmodium screens 
cover only the erythrocytic stages [56, 57], with the 
exception of Stanway et al., which also covers other 
life cycle stages, but only provides data on two 
heme-containing enzymes in P. berghei [55]. The 
available T. gondii screens are limited to assessing 
the fitness cost in tachyzoites [10, 38]. The heme-
containing components of the ETC, cytochrome b 
and cytochrome c oxidase (complex IV) subunit I 
(COXI), are among the few proteins encoded in the 
highly reduced mitochondrial genomes of 
Plasmodium spp. and T. gondii [58, 59]. While these 
mitochondrial genes have not been targeted 
genetically, several lines of evidence indicate that 
they are essential: cytochrome b, encoded in the 
mitochondrial genome, is part of the cytochrome bc1 
complex, which is likely essential in Plasmodium and 
T. gondii, based on the essentiality of its nuclear 
encoded subunit, cytochrome c1 [10, 38, 56, 57]. 
Similarly, interactors of mitochondrially encoded 
COXI, which together form complex IV, are fitness 
conferring based on genome fitness screens. 
Furthermore, various antimalarials, including the first 
line drug atovaquone, target cytochrome b within the 
cytochrome bc1 complex [60, 61]. Lastly, the 
mitochondrial ribosomes, which in Plasmodium only 
translate one other heme-independent protein, the 
cytochrome c oxidase subunit III (COXIII), are 
essential [62, 63]. Curiously, the T. gondii nuclear 
genome encodes partial copies of the mitochondrial 
Fig. 2. The fitness-conferring role of heme containing enzymes in P. falciparum, P. berghei and T. gondii. 
This figure, adapted from van Dooren et al., lists the heme-containing enzymes in Plasmodium and T. gondii. For each 
gene, the fitness score from recent genome wide fitness screens is given where available. Gene annotations in red represent 
those encoded on the mitochondrial genome, for which no fitness screen data is available to date. Based on the available 
screens, cytochrome c1, cytochrome c and cytochrome b5-1 are likely fitness-conferring or essential in both Plasmodium 
erythrocyte stages and T. gondii tachyzoites. Intriguingly, the sole cytochrome P450 in T. gondii is dispensable, while its 
overexpression is associated with enhanced pathogenicity (see Zhang et al., 2017, Oncotarget, Functional characterization 
of a unique cytochrome in Toxoplasma gondii).  
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cytochrome b and COXI [64], although their 
functional significance is unknown. 
 
Looking beyond Apicomplexa, the demand for heme 
also differs drastically between other organisms. 
Cytochromes of the mitochondrial respiratory chain 
form one of the largest groups of heme-containing 
enzymes and thus are a major sink for heme in most 
cells. The exception to this are anaerobic organisms, 
such as Entamoeba, Trichomonas and Giardia, 
which have no or reduced respiratory chain activity, 
likely accompanied by a reduced requirement for 
heme [22]. This is exemplified by Entamoeba 
histolytica which lacks a conventional mitochondrion 
and thus expresses no cytochromes or other heme-
containing proteins [22, 65, 66]. However, proteins 
involved in trafficking iron and heme have been 
identified in E. histolytica and it has been proposed 
that the parasite secretes heme-binding proteins as 
a mechanism for iron acquisition. More surprisingly, 
a homologue of ferrochelatase (FECH), the enzyme 
catalyzing the final step in the heme synthesis 
pathway, was identified  [67, 68]. However, it 
remains unclear if the putative FECH of E. histolytica 
is functional, and whether these parasites have any 
requirement for heme, besides serving as an iron 
source. Another anaerobic parasite, Giardia 
intestinalis, expresses five heme proteins and 
incorporates heme into a soluble cytosolic form of 
cytochrome b5 of unknown function [69, 70]. While 
most organisms require heme to some degree, the 
kinetoplastid plant parasite Phytomonas serpens is 
highly atypical in that it is able to survive and grow 
entirely devoid of heme [71]. P. serpens does not 
require heme for its ETC and lacks many of the 
proteins known to contain heme. While its synthesis 
of ergosterol relies on the heme-dependent 
lanosterol 14α-demethylase (CYP51), P. serpens 
can survive by incorporating the ergosterol precursor 
lanosterol into its membranes, making it the only 
known aerobic eukaryote able to grow in the 
absence of heme [71].  
 
Availability and uptake of exogeneous heme in 
Apicomplexa 
The availability of exogeneous heme throughout the 
development of Apicomplexa also varies. T. gondii 
tachyzoites can replicate within most cell types, 
however labile, non-protein bound heme levels are 
low in the host cytosol (~25 nM, [72]) and the vast 
majority of heme is sequestered by chaperones or 
incorporated into proteins and may be difficult to 
access. Bradyzoites face the same challenge within 
neurons and muscle cells [73], however the 
surrounding cyst wall has been shown to be largely 
permeable for compounds <10 kDa and fully 
permeable for compounds <1 kDa [74], suggesting 
that any free heme, with a molecular weight of 615 
Da, could freely pass into the vacuole. Similarly, 
heme is likely abundantly present for salvage by 
schizonts and gametes in the cat intestine, where it 
is taken up into epithelial cells through the heme 
carrier protein 1 (HCP1) [75]. Free environmental 
oocysts, however, likely have no access to 
exogeneous heme and must rely on de novo 
synthesis or significantly reduced demand during 
this quiescent life cycle stage.  
 
Particularly striking are the differences in heme 
availability during the life cycle of Plasmodium spp. 
Throughout the asexual development in 
erythrocytes, Plasmodium relies on the ingestion 
and proteolytic digestion of hemoglobin to fulfill its 
amino acid needs and thereby releases large 
amounts of heme [76, 77]. During replication, 
parasites take up such large amounts of hemoglobin 
that heme concentration reaches toxic levels within 
the food vacuole, and must be detoxified through 
deposition in a crystalline structure, termed 
hemozoin [78]. The mechanism of hemozoin 
formation has been well studied in Plasmodium, due 
to its importance as a target for antimalarial drugs, 
and will not be discussed in detail here [79-84]. The 
vast majority of heme released from hemoglobin 
digestion is confined within the food vacuole as 
hemozoin [85]. However, parasites deficient of heme 
synthesis grow and develop unimpaired in red blood 
cells (RBCs), highlighting that Plasmodium utilizes 
host derived heme for cellular functions [12-15]. In 
contrast to the heme-rich milieu in the blood, heme 
availability may be limited in the mosquito gut and in 
hepatocytes. In the mosquito gut, heme is expected 
to gradually decline following the blood meal as it is 
excreted or absorbed into tissues and used for egg 
development [86], while heme levels in the salivary 
gland are unknown. Plasmodium spp. must 
therefore be able to carefully meet its varying heme 
demand, while facing fluctuating environmental 
conditions ranging from heme limiting to toxic levels.  
   
Apicomplexa and other parasites have evolved 
expert strategies to exploit the metabolism of their 
host, salvaging various nutrients including sugars, 
amino acids, nucleobases, lipids, fatty acids, 
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vitamins and co-factors [21, 30, 87, 88]. Hence, 
many parasites have lost the capacity to synthesize 
certain metabolites and have developed scavenging 
mechanisms, allowing the pathogens to save energy 
by reducing their genome and metabolic capabilities 
[89]. The heme auxotroph trypanosomatid 
Leishmania amazonensis expresses a gene with 
45% similarity to a C. elegans heme transporter [90, 
91]. Remarkably, expression of this divergent 
Leishmania Heme Response-1 (LHR-1) protein in a 
yeast strain deficient in heme synthesis restored its 
growth [90]. LHR-1 is essential for Leishmania 
promastigotes and virulence in mice [90, 92] and a 
related transporter was later identified in 
Trypanosoma brucei [93]. More recently, another 
plasma membrane transporter, the feline leukemia 
virus subgroup C receptor-related protein 
(LmFLVCRb), was shown to be implicated in heme 
transport in Leishmania major and is essential for 
virulence [94]. Trypanosomatids, which possess 
more heme containing proteins than T. gondii or 
Plasmodium spp. [22], but lack functional heme 
synthesis pathways and rely on its salvage, can 
nonetheless survive and propagate in environments 
in which heme-levels fluctuate and may reach 
critically low levels, such as the digestive tract of 
insect vectors [90, 95, 96] (reviewed in [97]). Instead, 
Plasmodium is unable to acquire sufficient heme in 
the similar environment of the mosquito’s digestive 
tract [12, 13]. This suggests that Plasmodium spp. 
lack specific heme uptake mechanisms which allow 
the efficient uptake of heme, or that Plasmodium has 
a particularly high requirement for heme during 
oocyst maturation which cannot be met by uptake. 
Similarly, growth impaired T. gondii, in which a heme 
synthesis enzyme was deleted, could not be rescued 
by provision of exogenous heme [9, 10], indicating 
that T. gondii is unable to efficiently salvage heme. 
Indeed, no heme transporters have been identified 
in apicomplexans to date but specific transporters or 
other unidentified uptake mechanisms must exist in 
various species such as the Gregarina and Theileria 
which lack enzymes of the heme biosynthesis 
pathway but encode heme-containing enzymes.  
 
Heme synthesis enzymes in Apicomplexa: 
conservation, localization and evolutionary 
origin 
The enzymes encoding the heme synthesis pathway 
have been lost multiple times in the evolution of 
parasitic protozoans, including from entire families, 
such as Trypanosoma, Giardia and Trichomonas, 
but have typically been maintained in free-living 
protists such as Chromera velia [22]. Figure 3 
summarizes the conservation of heme synthesis 
enzymes across selected parasitic protozoa. Within 
the Apicomplexa, the ability to synthesize heme has 
also been lost several times; Piroplasmida including 
Babesia and Theileria, as well as Cryptosporidia and 
Gregarina are all missing some or all of the enzymes 
of the heme biosynthetic pathway and are hence 
unable to synthesize heme [22, 23, 98] (Figure 3). 
From examining available genomes, it is anticipated 
that Cryptosporidia have a low requirement for heme 
due to the lack of cytochromes. Babesia and 
Theileria also lack components of this pathway but 
encode cytochromes and a heme oxygenase-like 
protein [23], which was shown in Plasmodium to bind 
heme and its precursor protoporphyrin IX (PPIX), but 
does not catalyze heme degradation, suggesting an 
alternative function [99]. Thus, Babesia and Theileria 
appear to have some requirement for heme and 
must scavenge it from their hosts through a currently 
unknown mechanism [23]. In contrast, T. gondii and 
Plasmodium spp. express all of the enzymes 
necessary to synthesize heme de novo [23, 100] 
(Figure 3). Given the loss of many metabolic 
pathways in parasitic protozoa, the ability to 
synthesize heme was probably only retained in 
parasites where salvage of heme or its precursors 
was not possible throughout the complete life cycle.  
 
Heme can be synthesized de novo from simple 
amino acids and organic acids in 8 or 9 enzymatic 
reactions [101]. While animals and fungi synthesize 
heme from succinyl-CoA and glycine (C4-pathway) 
in the mitochondria and cytosol, plants generate 
heme from glutamyl-tRNA (C5-pathway) in the 
plastid and mitochondria. Both, the C4- and C5-
pathway occur in bacteria, although the C5-pathway 
is more common [102]. In animals, the initial step of 
heme biosynthesis is catalyzed by 5-aminolevulinate 
synthase (ALAS) and takes place in mitochondria, 
generating 5-aminolevulinate (ALA) from glycine and 
succinyl-CoA [103].  
ALA is transported out of the mitochondria and the 
subsequent four steps occur in the cytosol, 
producing coproporphyrinogen III (CPPgenIII). 
CPPgenIII is trafficked back across the outer 
mitochondrial membrane and is converted to PPIX 
which is transported across the inner mitochondrial 
membrane and converted to heme, through the 
incorporation of iron by FECH [103]. 






















































Fig. 3. Conservation and fitness-conferring roles of heme biosynthesis enzymes across selected protists. 
Enzymes required for heme synthesis have been lost independently in a number of parasitic protists. Where studied, 
the importance for heme synthesis across the sexual (lower half circle) and asexual (upper half circle) life cycle phases 
of these parasites is indicated (references given in the text). In addition to heme synthesis, some parasites are able or 
predicted to scavenge heme or its porphyrin precursor from their environment, although in most cases the transporters 
have not been identified or characterized. Abbreviations: ALAS, 5-aminolevulinate synthase; ALAD, 5-aminolevulinate 
dehydratase; PBGD, porphobilinogen deaminase; UROS, uroporphyrinogen III synthase; UROD, uroporphyrinogen 
decarboxylase; CPOX, coproporphyrinogen III oxidase; CPDH, (oxygen independent) coproporphyrinogen III 
dehydrogenase; PPOX, protoporphyrinogen oxidase; FECH, ferrochelatase. Cartoons of parasites are adapted from 
Servier Medical ART available under smart.servier.com 
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While most enzymes in this pathway originated from 
the eukaryotic nucleus, ALAS and the 
uropophyrinogen synthase (UROS) have been 
proposed to be of α-proteobacterial origin [100, 104]. 
In contrast to the mammalian pathway, heme 
synthesis in plants occurs in the plastid. However, 
the final two enzymes dually localize to the plastid 
and to the mitochondria, thus, heme can be 
synthesized in the plastid, or in the mitochondria 
following import of PPIX. PPIX is also an 
intermediate of chlorophyll, which is generated 
exclusively in plastids. Hence, PPIX is either 
processed by the FECH to generate heme or by the 
magnesium chelatase, committing to chlorophyll 
synthesis. The flux through these two pathways is 
regulated at multiple levels to balance heme and 
chlorophyll abundance [105]. Unsurprisingly, most 
enzymes in the heme synthesis pathway of plants 
are of cyanobacterial origin, however, the 
porphobilinogen deaminase (PBGD) has been 
described to be of α-proteobacterial origin and the 
coproporphyrinogen oxidase (CPOX) may be 
derived from the primary host nucleus [100, 104]. 
Some heme synthesis enzymes have been 
proposed to interact with each other, forming 
supramolecular protein complexes which facilitate 
the shuttling of intermediates and increase the 
efficiency of the pathway [106].  
 
Within the apicomplexans, phylogenetic analyses 
revealed a hybrid heme synthesis pathway, 
reflecting the unique evolutionary history of these 
parasites [22, 100, 107-109]. Generation of ALA 
from succinyl-CoA and glycine is catalyzed by ALAS 
in the mitochondrion, as in animals and yeast. In T. 
gondii, the succinyl-CoA is expected to be derived 
from the TCA cycle, as inhibiting the pathway 
resulted in a decrease in heme production [16], while 
glycine can be derived from serine in the cytoplasm 
or directly salvaged from the host and transported to 
the mitochondria [110]. The subsequent four steps 
occur in the apicoplast, a relict plastid organelle 
derived from secondary endosymbiosis of a red alga 
[108, 111, 112]. CPPgenIII is then transported to the 
cytosol where CPOX, which catalyzes the 
conversion of CPPgenIII to PPgenIX, is localized 
[113]. CPOX is cytosolic in fungi and yeast, however, 
it localizes to the mitochondria in animals [103]. 
Curiously, coccidians and chromerids express a 
putative oxygen-independent bacterial-type 
coproporphyrinogen III dehydrogenase (CPDH) 
which is also predicted to catalyze the conversion of 
CPPgenIII to PPgenIX, via a radical s-adeonsyl-
methionine (SAM) mechanism [88, 101, 102, 110]. 
The final two enzymes of the pathway, PPOX and 
FECH, localize to the mitochondrion in Plasmodium 
spp. and T. gondii [114, 115]. Figure 4 highlights the 
structures of heme intermediates, the enzymes and 
their respective localization in animals, plants and 
apicomplexans.  
 
The initial apicomplexan heme synthesis enzyme, 
ALAS, is, as in animals and yeast, of α-
proteobacterial origin. The four subsequent 
apicoplast-localized enzymes have been proposed 
to be of varying origin but are at least partially 
derived from cyanobacterial origin [22, 100]. 
Curiously, although the localization of PPOX 
resembles that in animals, it has been proposed to 
be of cyanobacterial origin [22, 100, 107]. The 
FECH, in contrast, is of proteobacterial origin [116]. 
This peculiar hybrid pathway including enzymes 
from various ancestors dispersed over three cellular 
compartments is so far unique to apicomplexans and 
closely related organisms [98, 117, 118]. It has been 
speculated that the mitochondrial/cytosolic- and the 
plastid-localized heme synthesis pathway probably 
co-existed following the endosymbiotic acquisition of 
the plastid [23]. Over time, transporters enabling the 
redistribution of intermediates between organelles 
were acquired or developed from other existing 
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The role of heme synthesis in Plasmodium 
Heme synthesis in Plasmodium spp. follows the 
enzymatic reactions outlined above. However, the 
importance of de novo synthesis changes 
throughout Plasmodium’s complex lifecycle where it 
faces vastly different environments in terms of heme 
abundance and must adapt its metabolism 
accordingly [45, 55, 57]. Early studies proposed that, 
despite the uptake of large amounts of host derived 
heme, Plasmodium de novo heme synthesis is 
active in RBCs and provides a promising drug target 
[119]. However, later on, many of the enzymes of the 
pathway have been directly knocked-out, including 
ALAS, PBGD, CPOX, uroporphyrinogen 
decarboxylase (UROD) and FECH with no defects in  
intraerythrocytic parasite replication or gametocyte 
conversion [12-15, 120, 121]. Two studies used 13C-
labelled ALA and mass spectrometry to specifically 
probe de novo heme biosynthesis in Plasmodium 
[12, 15]. While both studies showed that labelled 
atoms derived from 13C-ALA are incorporated into 
parasite derived heme in intraerythrocytic wildtype 
parasites, Sigala et al. showed that this activity is 
dependent on residual heme synthesis enzymes in 
the RBC upon non-physiological provision of 
exogeneous ALA, as neither saponin-lysed asexual 
parasites nor gametocytes utilized 13C-ALA for heme 
synthesis [15].  
 
In contrast to the high levels of heme present in 
erythrocytes, parasites likely have limited access to 
exogeneous heme in the mosquitos. Deletion of both 
ALAS and FECH resulted in a defect in male gamete 
formation, reduced oocyst numbers and a lack of 
sporozoites in the salivary gland, indicating a block 
in transmission of both P. berghei and P. falciparum 
[12, 13]. Two subsequent studies confirmed a defect 
in oocyst maturation in P. berghei upon obstruction 
of either mitochondrial ALAS and FECH or the 
apicoplast resident heme synthesis enzymes, PBGD 
and UROD [14, 121]. While Rizopoulos et al. 
reported that liver stage development, although 
retarded, could be completed by parasites lacking 
ALAS, Nagaraj et al. proposed that heme synthesis 
is absolutely essential for liver stage development 
[13, 14]. Both studies highlighted that 
supplementation with exogeneous ALA in mice or 
mosquitos could rescue the phenotypes of parasites 
lacking ALAS [13, 14], seemingly consistent with the 
observation that Plasmodium spp. can salvage 
exogeneous ALA for heme synthesis [12]. 
Rathnapala et al. later used a novel approach to 
Fig. 4. Heme synthesis in plants, animals and 
apicomplexans. 
Plants, animals and humans synthesize heme using a similar 
set of enzymes. In apicomplexans, as well as in animals, 5-
aminolevulinate (ALA) is generated from glycine and succinyl-
CoA, catalyzed by the 5-aminolevulinate synthase (ALAS). In 
contrast, plants generate ALA from glutamyl-tRNA (GluT) 
using GluT reductase (GluTR) and glutamate 1-semialdehyde 
aminotransferase (GSA-AT). The subsequent enzyme 
reactions are identical, but the localization of the enzymes 
differ between organisms. Plants synthesize heme in the 
chloroplast, while the last two enzymes dually localize to the 
chloroplast and mitochondria. In animals, heme synthesis 
occurs in the mitochondria and cytosol. Uniquely, heme 
synthesis enzymes are dispersed across three cellular 
compartments in the apicomplexans: the mitochondrion, 
apicoplast and cytosol. Abbreviations: ALAS, 5-
aminolevulinate synthase; ALAD, 5-aminolevulinate 
dehydratase; PBGD, porphobilinogen deaminase; UROS, 
uroporphyrinogen III synthase; UROD, uroporphyrinogen 
decarboxylase; CPOX, coproporphyrinogen III oxidase; 
PPOX, protoporphyrinogen oxidase; FECH, ferrochelatase. 
J. Kloehn, C. R. Harding and D. Soldati-Favre  Heme in Apicomplexa 
 11
demonstrate that FECH deficient sporozoites, 
distinguishable by fluorescence from FECH 
expressing sporozoites, were unable to complete 
liver stage development [121]. In summary, heme 
synthesis is inactive and dispensable for 
intraerythrocytic stages but becomes essential 
during development in the mosquito vector and in 
the liver stages. The fitness-conferring roles of heme 
synthesis enzymes are summarized in Figure 3. 
 
The role of heme synthesis in Toxoplasma 
gondii 
In T. gondii the first demonstration of the importance 
of heme production came from chemical inhibition of 
ALAD using succinylacetone which led to a block in 
parasite replication [122]. The relevance of heme 
synthesis was further supported by a genome-wide 
CRISPR fitness screen, where all heme synthesis 
genes were assigned a fitness score of less than -2, 
indicating a fitness-conferring role in in vitro growth 
[38]. Recently, several enzymes of the pathway have 
been examined in detail [9-11], confirming that 
several heme synthesis enzymes are highly fitness-
conferring in T. gondii (ALAS, ALAD, PPOX, CPOX), 
although interestingly, so far only FECH was found 
to be essential in tachyzoites under standard culture 
conditions [9-11] (Figure 3).  
 
Deletion of the first enzyme in the T. gondii heme 
pathway, ALAS, caused a significant reduction in 
parasite replication [9, 10]. Krishnan et al., reported 
full restoration of heme levels and rescue of parasite 
growth following supplementation with ALA, while 
Bergmann et al., only reported partial restoration of 
intracellular heme levels and a relatively poor 
restoration of fitness. This may reflect variations in 
techniques or possibly the level of adaptation which 
occurred during the generation and selection of 
these mutant strains. The subsequent enzymes 
operating in the apicoplast: ALAD, PBGD and UROS 
have not been disrupted individually to date and it 
remains unclear whether these are essential. A 
fitness-conferring role as for the other enzymes in 
the pathway is anticipated given the data from a 
genome-wide fitness screen [38]. T. gondii ALAD 
(also known as porphobilinogen synthase, PBGS) 
has been characterized biochemically and 
structurally [122, 123]. These studies revealed that 
an extended C-terminus of the T. gondii enzyme is 
responsible for an unusual octamer formation, which 
does not require metal ions for its stability [122, 123]. 
The functional significance of these alterations 
remains to be determined and may provide a 
possible novel drug target. Furthermore, 
pharmaceutical inhibition of ALAD using 
succinylacetone indicated essentiality of the enzyme 
and the heme synthesis pathway [122]. However, it 
remains unclear how inhibition of the host cell ALAD 
affected parasite growth in these experiments and 
off-target effects cannot be excluded and have been 
suggested [120].  
 
The enzyme catalyzing the last step of heme 
synthesis in the apicoplast, UROD, has been 
disrupted genetically [11]. Down-regulation of UROD 
is associated with a reduction in free heme levels, as 
well as a dramatic reduction in parasite growth and 
fitness. In this study, heme intermediate levels were 
not quantified, and it is unknown if these parasites 
could be rescued through addition of ALA. The 
CPPgenIII synthesized by UROD is exported across 
the four membranes of the apicoplast through an 
unidentified transporter or transporters to the 
cytosol. Once there, CPOX converts CPPgenIII into 
PPgenIX, the only reaction which occurs in the 
cytosol [9, 113]. In addition to CPOX, T. gondii 
encodes another oxygen-independent enzyme 
(CPDH) potentially catalyzing the same reaction. 
CPDH is only found in the coccidians but is predicted 
to be dispensable in tachyzoites [38] which was 
recently confirmed experimentally [10]. Parasites 
lacking CPDH had no fitness defect, while those 
lacking either CPOX or both enzymes showed 
equally reduced intracellular heme levels and a 
similar dramatic reduction in growth and fitness, 
excluding a redundant function in tachyzoites. CPDH 
expression is upregulated in bradyzoites during 
chronic infection, when parasites might have to cope 
with reduced oxygen levels in large cysts. However, 
Krishnan et al. identified no defect in cyst size or 
number in parasites lacking CPDH [10]. Hence, the 
function of the conserved CPDH in the coccidian 
subgroup of Apicomplexa remains unclear. It may 
have a role in the sexual life cycle stages, where it is 
upregulated, and future studies may be able to 
investigate this intriguing question [124].   
 
CPOX generates PPgenIX in the cytosol which is 
then transported into the mitochondrion and 
converted to PPIX by PPOX. Deletion of PPOX also 
resulted in reduced heme levels and a loss of 
parasite fitness [9]. However, compared to other 
knockouts (KOs) in the pathway, deletion of PPOX 
has a milder phenotype [9], in a similar manner to 
J. Kloehn, C. R. Harding and D. Soldati-Favre  Heme in Apicomplexa 
 12
Saccharomyces cerevisiae where PPOX is the only 
non-essential heme synthesis enzyme  [125]. It is 
possible that oxidation of PPgenIX to PPIX may 
occur inefficiently without enzymatic activity of 
PPOX, which would explain why loss of PPOX is 
tolerated at a significant but less severe fitness cost 
compared to other enzymes in the same pathway 
[9]. Spontaneous oxidation of PPgenIX has been 
previously suggested [126] but it remains unclear to 
what extent it occurs in vivo. Interestingly, in 
apicomplexans, PPgenIX is generated in the cytosol, 
while in animals it is likely produced in the 
mitochondria. In apicomplexans, the cytosolic milieu 
may thus facilitate the spontaneous oxidation due to 
its higher oxygen concentration and lower reducing 
redox potential compared to mitochondria [127-129]. 
For PPIX, derived from spontaneous oxidation of 
PPgenIX, to contribute to heme synthesis, it must be 
transported into the mitochondrion, which 
presupposes that the mitochondrial transporter does 
not discriminate between PPIX and PPgenIX. The 
existence and importance of spontaneous oxidation 
in the cytosol remains to be determined and may rely 
on the identification of the putative transporter. 
Despite their fitness-conferring role, several targeted 
genes upstream of FECH (ALAS, CPOX, PPOX) 
could be deleted successfully. While their loss 
severely affected growth, viable parasites could be 
maintained in culture [9, 10]. The final step in the 
construction of heme is the incorporation of iron 
(Fe2+) into the porphyrin ring by FECH. Strikingly, 
despite multiple attempts, a KO of FECH could not 
be generated [9, 10] and parasites conditionally 
depleted of FECH failed to propagate in culture [10]. 
Taken together, the results of these recent 
independent studies showed that enzymes of the T. 
gondii heme synthesis pathway are highly fitness-
conferring and their loss is associated with a 
dramatic reduction, but not a complete loss of heme 
in cultured tachyzoites. Thus far, only the final 
enzyme, FECH, was identified to be essential in 
cultured tachyzoites. While the rich culture medium 
in vitro may allow survival of parasites lacking ALAS, 
CPOX or PPOX, all mutant strains were found to be 
avirulent in mice, highlighting that heme synthesis is 
essential for virulence in vivo [9].   
 
Beyond tachyzoites, little is known about the role of 
heme synthesis in other life-cycle stages of T. gondii 
and can  only be inferred from RNA sequencing data 
[124]. Based on RNA expression data, it appears 
that heme synthesis may be least active in 
bradyzoites, as all enzymes of the pathway are 
repressed, except for the putative oxygen 
independent CPDH [124]. Perhaps most relevant is 
the expression level of ALAS, a rate-limiting enzyme 
in other organisms [130]. ALAS expression is 
reduced in all life cycle stages compared to 
tachyzoites, possibly indicating reduced activity of 
the heme synthesis pathway [124]. In yeast, ALAD 
and PBGD have also been proposed to have rate-
limiting functions [131]. The former is down-
regulated in all life-cycle stages compared to 
tachyzoites. PBGD, on the other hand, is only down-
regulated dramatically in bradyzoites [124]. Slow 
growing bradyzoites likely have generally reduced 
metabolic demands compared to the rapidly 
replicating tachyzoites. Additionally, as discussed 
above, bradyzoites are likely less dependent on ATP 
generation through OXPHOS, which may further 
contribute to reduced heme requirements and thus 
reduced synthesis [34, 35]. However, it remains 
unclear if bradyzoites truly have reduced heme 
requirements, and if these are met through 
depressed de novo synthesis or if bradyzoites 
increasingly rely on scavenging.  
 
Regulation of heme synthesis in Apicomplexa 
In model organisms, heme synthesis is highly 
regulated at multiple levels based on the state of the 
cell and availability of precursors [103, 131, 132], 
e.g. ALAS activity is inhibited by binding to heme, 
allowing negative regulation of heme production 
[133]. In extracellular parasites, addition of ALA 
leads to an excess of PPIX but no or only a modest 
increase in heme, indicating that ALA stimulates 
PPIX synthesis in T. gondii, while FECH is rate 
limiting for its conversion to heme [16]. The same 
effect of ALA supplementation is well known for 
mammalian cells and has been exploited for 
photodynamic therapy of cancer cells which become 
light sensitive upon PPIX accumulation [134-136]. In 
Apicomplexa, ALAS likely has a rate-limiting function 
[137], consistent with the presence of a cysteine-
proline dipeptide (CP-motif) in the N-termini of T. 
gondii and P. falciparum ALAS [23, 100]. These CP-
motives enable the transient binding of heme and 
are the most prominent heme-regulatory motif 
(HRM) [138]. While binding of heme to these HRMs 
typically modifies the stability and/or catalytic 
activity, Varadharajan et al., provide evidence that 
excess heme disables the translocation of ALAS into 
the mitochondrion of P. falciparum, thus regulating 
its activity [137]. Another study proposed that, not 
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only ALAS, but also ALAD (PBGS) is inhibited by 
heme in a concentration-dependent manner in 
Plasmodium knowlesi [139]. The absence of a CP-
motif in the N-terminus of the P. knowlesi enzyme 
suggests a different mode of regulation. In contrast 
to the Plasmodium and human ALAD, the T. gondii 
ALAD has a ~200 amino acid extended N-terminus 
which also includes a CP-motif, possibly involved in 
regulating its activity. Using experimental or 
computational approaches to identify heme-
regulatory motives and determine unknown protein-
heme interactions could be one way of identifying 
regulatory mechanisms of heme synthesis in 
Apicomplexa [138].  
 
Other elegant studies have helped to reveal complex 
putative regulatory mechanisms: it was shown that 
ablation of the function of the protease DegP2 leads 
to a reduction in heme levels in both T. gondii and P. 
falciparum [16]. DegP2 is outside of the canonical 
heme synthesis pathway and its targets within the 
cell remain unknown [16, 17]. However, in both yeast 
and mammalian cells, the protease ClpX partially 
unfolds ALAS and thereby aids in the incorporation 
of its cofactor, pyridoxal 5-phosphate, enabling its 
activity [140]. A related regulatory role could be 
carried out by DegP2 in the Apicomplexa. If, or how 
DegP2 senses heme levels is unclear, but it does 
include a CP-motif in its N-terminus. Further 
research into potential regulation of this pathway in 
the parasites would be valuable in determining the 
diversity of regulatory approaches utilized by 
eukaryotes.  
 
Metabolic adaptations in heme-depleted 
Toxoplasma gondii tachyzoites 
Heme acts a key prosthetic group within several 
enzymes. In T. gondii, 14 proteins are predicted to 
contain heme (Figure 2), 4 of which are required for 
the ETC [22, 23]. It is likely that depletion of heme-
bound cytochromes in the ETC is largely responsible 
for the fitness defect seen upon depletion of heme. 
Tachyzoites acquire the majority of their ATP 
through OXPHOS [33] and indeed, depletion of 
heme by down-regulation of UROD or straight KO of 
CPOX leads to a dramatic decrease in mitochondrial 
respiration [10, 11] and a drop in ATP levels [11]. 
Upon deletion of CPOX, parasites respond to the 
drop in mitochondrial respiration by markedly 
increasing the rate of glycolysis, although it is likely 
that this cannot fully compensate for the hampered 
ATP production in these parasites [10]. Interestingly, 
upregulation of glycolysis was not seen in parasites 
conditionally depleted of UROD. However, it is 
possible that over the relatively long process of 
generating a ΔCPOX parasite line, adaptation 
occurred, leading to selection of parasites with 
markedly increased rates of glycolysis. In contrast, 
the sudden loss of enzyme function upon conditional 
depletion was likely too rapid for the parasite to 
compensate in this way. This potential adaptation 
highlights the possible metabolic flexibility of T. 
gondii and underlines the caution required in 
interpreting metabolic phenotypes after genetic 
perturbations. These findings have implications for 
potential drug treatment. Parasites appear unable to 
adapt to a sudden drop in heme synthesis but may 
be able to adapt over longer periods to move away 
from OXPHOS and instead rely on glycolysis for 
energy generation. Regardless of the partial 
adaptation of these parasites, the dramatic fitness 
defect of heme-deficient parasites in vitro and 
particularly in vivo suggests that heme synthesis 
enzymes may be promising drug targets to treat 
toxoplasmosis [9-11]. 
 
Whether other metabolic adaptations are necessary 
to survive under a markedly reduced heme level 
remains unclear. As discussed above, the 
desaturation of stearate is also dependent on heme 
but likely dispensable for T. gondii [39]. Oleate is one 
of the most abundant fatty acids in  mammalian 
tissues and cells [141]. Thus, it may be salvaged by 
T. gondii and can be further elongated to generate 
the T. gondii-specific, long chain mono-unsaturated 
fatty acids which are essential [40]. However, 
Ramakrishnan et al. have proposed that elongases 
preferentially act on de novo synthesized oleate [40] 
and the role of lipid metabolism in the growth 
phenotypes in the absence of heme has not yet been 
examined.  
 
Scavenging and intracellular trafficking of heme 
intermediates in Apicomplexa 
As obligate intracellular parasites, apicomplexans 
have the option to scavenge metabolites from their 
hosts. The results above strongly suggest that T. 
gondii is unable to take up exogenous heme, 
however metabolic intermediates in the heme 
synthesis pathway do appear to be taken up and 
utilized. Treatment of extracellular T. gondii with ALA 
leads to an increase in PPIX levels [16], 
demonstrating that the parasites can take up and 
utilize this first committed metabolite. Furthermore, 
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ALA supplementation can rescue heme level and 
growth in mutant parasites lacking CPOX, although 
CPOX is downstream of ALA, suggesting that 
parasites can take up the excess PPIX generated by 
the host cells. This points towards a potential PPIX 
salvage pathway in the parasite, which is then 
converted to heme by T. gondii FECH [10]. Crucially, 
this salvage mechanism appears inefficient and 
parasites are severely impaired under physiological 
conditions. In order to be salvaged, intermediates 
must make their way to the correct destination within 
the cell. The membrane of the parasitophorous 
vacuole (PV) has been described as a molecular 
sieve, through which small metabolites like ALA and 
PPIX  (<3 kDa) [142] can pass through passive 
diffusion. The parasite plasma membrane and 
mitochondrial membrane provide more substantial 
barriers. As for T. gondii, uptake of host derived 
PPIX and its conversion to heme through the 
parasite FECH was also demonstrated in 
intraerythrocytic P. falciparum. While mature 
reticulocytes lack mitochondria and thus lack ALAS 
as well as FECH activity, Sigala et al. elegantly 
demonstrated that exogeneous ALA was 
incorporated into parasite derived heme, including in 
parasites which lack CPOX or PBGD. These 
observations revealed that PPIX synthesis 
surprisingly occurs in mature RBCs provided with 
exogeneous ALA and that host derived PPIX is 
taken up by P. falciparum and converted to heme 
inside the parasite’s mitochondrion [15]. The findings 
by Krishnan et al. and Sigala et al. strongly support 
the existence of PPIX transporters at the plasma 
membrane as well as in the inner mitochondrial 
membrane in T. gondii and P. falciparum, which 
have not been identified to date. 
Uptake of PPIX through an unidentified mechanism 
has also been described in Leishmania major, where 
salvaged PPIX is converted to heme through the 
parasite’s FECH [95]. However, the role of this 
salvage pathway in vivo is unclear, as the 
Leishmania FECH is not required for development in 
the sandfly or for the formation of skin lesions in mice 
[95].  
 
Intriguingly, while ALA supplementation has been 
widely used in studies probing heme synthesis in T. 
gondii and Plasmodium and was shown to rescue 
the phenotype of parasites lacking ALAS [9, 10, 12-
15], it remains unclear if intracellular parasites 
actually take up exogeneous ALA or largely acquire 
late intermediates benefitting from the ALA induced 
increase in host PPIX [10, 15]. The latter is strongly 
supported by the observations by Krishnan et al. and 
Sigala et al., who showed that T. gondii lacking the 
enzyme CPOX downstream of ALAS can also be 
rescued by ALA supplementation and similarly that 
ALA-induced heme synthesis was occurring in P. 
falciparum which lack PBGD or CPOX [10, 15]. 
However, ALA is likely salvaged given that it is a 
small metabolite which easily passes the PV and 
may be transported across the plasma membrane 
using a specific ALA transporter or unspecific small 
polar metabolite transporters. Indeed, Harding et al. 
demonstrated that extracellular T. gondii tachyzoites 
take up exogeneous ALA resulting in increased 
PPIX levels [16], so that both mechanisms, salvage 
of ALA as well as PPIX, are likely utilized by 
parasites with a defect in heme synthesis.  
 
Besides the acquisition of heme intermediates 
across the plasma membrane, apicomplexans must 
rely on several transporters to traffic heme synthesis 
intermediates between organelles. Due to the 
patchwork nature of the heme biosynthesis pathway, 
multiple transporters are predicted to be required 
which are not present in other eukaryotes, including 
an apicoplast ALA-importer and an apicoplast 
CPPgenIII exporter (Figure 5). Other transporters 
are likely functionally homologous to mammalian 
transporters. In mammalian cells, the transporter 
ABCB6 has been proposed to be a porphyrin 
transporter in the outer mitochondrial membrane, 
possibly transporting CPPgenIII into the 
intermembrane space of mitochondria [143-145]. 
However, the role and localization of ABCB6 have 
been a matter of debate [146, 147] and it has been 
proposed that small metabolites cross the outer 
mitochondrial membrane through relatively 
unspecific porin channels [106]. Another mammalian 
mitochondrial ATP-binding cassette transporter, 
ABCB7, likely functions in iron-sulfur cluster 
synthesis in the inner mitochondrial membrane [148] 
and has been proposed to interact with ABCB10 and 
FECH to form a complex which is required for heme 
synthesis [149]. We have identified a putative 
transporter in P. berghei (PBANKA_1364800) and T. 
gondii (TGME49_269000), which shares ~40% 
identity with ABCB7 and ABCB6. Both apicomplexan 
genes are reported to be essential based on 
genome-wide disruption approaches [38, 56] and the  
T. gondii protein TGME49_269000 localizes to the 
mitochondrial membrane according to the spatial  
proteomics method hyperplexed Localization of  




Organelle Proteins by Isotopic 
Tagging (hyperLOPIT-) data set [150]. The 
localization and fitness-conferring role of this ABC 
transporter are both consistent with a function in 
porphyrin transport, although its function remains to 
be characterized. Another putative transporter, 
transmembrane protein 14C (TMEM14C), has been 
implicated in the transport of PPIX from the 
mitochondrial intermembrane space into the 
mitochondrial lumen in mammalian cells [151]. 
Harding et al. identified a structural homologue of 





Although its function is currently unknown, deletion 
of TMEM14C is associated with increased sensitivity 
to the antimalarial ART, suggesting a possible role 
in heme metabolism [16]. While mammalian cells 
transport CPPgenIII across the outer mitochondrial 
membrane, Apicomplexa must transport PPgenIX 
based on the different localization of CPOX [9, 103, 
113]. Transport of heme intermediates across 
membranes may be facilitated by the known close 
physical association of the mitochondrion and 
apicoplast [152], however protein transporters are 
probably required to assist in the movement of  
molecules across the four membranes of the 
apicoplast and the double membrane of the 
Fig. 5. Several unidentified transporters must enable uptake and intracellular trafficking of heme intermediates in 
Apicomplexa. 
T. gondii and Plasmodium can take up protoporphyrin IX (PPIX) and 5-aminolevulinate (ALA), necessitating transporters 
in the plasma membrane of the parasite. Metabolites of this size are expected to freely diffuse through the parasitophorous 
vacuole. Besides these plasma membrane transporters, T. gondii and Plasmodium spp. must also express transporters in 
the mitochondrial and apicoplast membranes to allow the trafficking of heme intermediates between the synthesis enzymes 
which are dispersed across 3 cellular compartments. These parasite-specific transporters have not been identified to date 
but may be promising drug targets. Metabolites are depicted in blue, enzymes in black and transporters in purple. 
Abbreviations: gly, glycine; ALAS, 5-aminolevulinate synthase; ALA, 5-aminolevulinate; ALA-Exp, unidentified 5-
aminolevulinate exporter in the inner mitochondrial membrane; ALA-Imp, unidentified 5-aminolevulinate importer in the 
plasma membrane and apicoplast membranes; ALAD, 5-aminolevulinate dehydratase; PBG, porphobilinogen; PBGD, 
porphobilinogen deaminase; HMB, hydroxy methylbilane; UROS, uroporphyrinogen III synthase; UPgenIII 
uroporphyrinogen III; UROD, uroporphyrinogen decarboxylase; CPPgenIII, coproporphyrinogen III; CPPgenIII-Exp, 
unidentified exporter of  coproporphyrinogen III in the apicoplast membranes; CPOX, coproporphyrinogen III oxidase; 
CPDH, (oxygen independent) coproporphyrinogen III dehydrogenase; PPgenIX, protoporphyrinogen IX; PPgenIX-Imp, 
unidentified protoporphyrinogen IX importer in the plasma membrane and inner mitochondrial membrane; PPOX, 
protoporphyrinogen oxidase; PPIX, protoporphyrin IX; FECH, ferrochelatase. 
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mitochondrion. Identification of porphyrin 
transporters has proven to be challenging, even in 
well studied model organisms [106, 153-155] and 
novel techniques will likely be required to identify 
proposed transport mechanisms. Figure 5 provides 
an overview over the many unidentified transporters 
involved in the uptake of heme intermediates and 
their intracellular trafficking. 
 
Considering the disparate localization and diverse 
evolutionary origins, as well as the presence of 
unique intermediate transporters, the heme 
synthesis pathway is expected to provide several 
promising drug targets to tackle toxoplasmosis [9-
11]. An intriguing possibility is also to treat 
Plasmodium infection by provoking the accumulation 
of PPIX, which produces reactive oxygen species 
upon light exposure, leading to death of the parasite 
[15, 120].  
 
The role of heme in activation of artemisinin 
The unusual heme metabolism of Plasmodium is 
also thought to be a key facet in the activity of the 
antimalarial drug ART. ART and its derivatives, 
usually in combination with partner drugs, are 
frontline malaria treatments and play a vital role in 
malaria control across the world [156]. ART is a 
sesquiterpene lactone, derived from the Chinese 
medicinal herb Artemisia annua, which contains an 
endoperoxidase bridge. The activity of the drug 
depends on the  cleavage of this bridge [157], which 
a number of in vitro and in vivo studies have 
demonstrated requires the iron moiety found within 
heme [18, 158, 159]. Activation of the drug leads to 
alkylation of heme as well as hundreds of proteins 
[18, 160] and lipids [161] within the cell. This 
widespread alkylation is key to the drug’s rapid 
activity [162] as ARTs are quickly cleared in vivo 
[163].  
 
Heme is required for ART activation, and as heme 
levels are expected to vary across the Apicomplexa, 
the sensitivity to ART is also be expected to differ. 
Indeed, while Plasmodium spp. are exquisitely 
sensitive to ART, C. parvum (which has no heme 
biosynthesis and a low requirement for heme) is 
comparatively insensitive to ART [164]. Babesia 
spp., which are resident within erythrocytes, but do 
not take up large quantities of hemoglobin and do 
not form hemozoin [165] have an IC50 of around 100 
times greater than that of Plasmodium [166]. T. 
gondii, which relies on its endogenous heme 
biosynthesis pathway, displays an intermediate 
sensitivity to ART [16, 17]. Levels of heme also differ 
significantly throughout the cell cycle of Plasmodium 
[167] and this is reflected in changes in sensitivity to 
ART treatment. Early after invasion (ring stage), 
prior to ingestion of significant amount of host 
hemoglobin, parasites are less sensitive to ART 
treatment, compared to later in the cell cycle [168, 
169]. Together these data across the Apicomplexa 
hint that heme levels are related to ART-mediated 
toxicity, providing an unusual role for a metabolite in 
the mechanism of drug action. Interestingly, both 
Plasmodium and T. gondii demonstrate a higher 
sensitivity to ARTs than mammalian cells [170] 
despite the presence of heme synthesis in 
mammalian cells. Although there may be multiple 
reasons for this, including more robust cellular repair 
mechanisms in mammalian cells, metabolomic 
analysis has demonstrated a pool of labile heme in 
apicomplexan parasites [16], which is not detectable 
in mammalian cells [171, 172]. This soluble heme 
may have greater accessibility to the drug, allowing 
for greater or more rapid activation.  
 
Resistance of Plasmodium to ARTs is an important 
and developing clinical problem [173-175]. 
Treatment failure in the field is associated with point 
mutations in the kelch13 gene [176, 177], however 
the mechanism underlying this decreased sensitivity 
remains under debate [178-181]. Given the non-
specific nature of ART toxicity, it is likely that multiple 
pathways have roles in protecting or mitigating drug-
induced damage which will not be discussed here. 
However, given the key role heme has in drug 
activation, recent studies have suggested that 
uptake and degradation of host hemoglobin, and its 
concomitant release of labile heme has an important 
role in drug sensitivity [182, 183]. Indeed, recently it 
was shown that mutations in kelch13 directly impact 
on hemoglobin uptake and digestion, through 
alterations in a clathrin-independent endocytic 
mechanism [180, 182, 184]. These recent studies 
help to explain the mechanism of action of a number 
of other resistance-conferring mutations that have 
been found in vitro or from clinical samples [184-
187]. These studies show that kelch13 has a role in 
endocytosis, and that endocytosis and digestion of 
host hemoglobin is required for ART-mediated killing 
[182, 183, 188].   
 
To complement the work from Plasmodium, the 
genetically more tractable T. gondii has been 
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exploited to examine ART in a less heme-rich 
environment. Using both chemical mutagenesis and 
genome-wide CRISPR screens [16], mutants with 
decreased sensitivity to ARTs have been identified. 
Gratifyingly, both techniques identified the protease 
DegP2, which appears to modulate heme levels 
within the parasite through a currently unknown 
mechanism [16, 17]. Interestingly, detailed analysis 
of mutants recovered from chemical mutagenesis 
also uncovered changes in the copy number of 
mitochondrial DNA [17]. The mitochondrial DNA of 
apicomplexans is highly reduced but is known to 
encode two essential heme-containing cytochromes 
[58, 59], however the mechanism by which 
amplification of the mitochondrial genome 
decreases ART sensitivity is unknown [17]. 
CRISPR-based screening also allowed the 
identification of enzymes of both the TCA cycle and 
heme biosynthesis as mediating decreased ART 
susceptibility [16]. Chemical inhibition of either 
pathway reduced levels of labile heme within the 
parasites, in concert with decreased ART-
susceptibility. The finding in T. gondii that heme 
levels appear to be the major determinant of ART 
susceptibility, supports work from Plasmodium, as 
well as confirming the TCA cycle as the source of 
precursors for heme synthesis, and demonstrated 
the power of CRISPR screens as tools to determine 
relevant pathways involved in the mechanism of 




The synthesis of heme is highly conserved across 
the kingdoms of life [189]. Within the parasitic 
Apicomplexa phylum, heme production is 
differentially required across species and even life 
cycle stages. The changes in production are 
influenced by both the supply of exogenous heme to 
scavenge and the demand for heme, which is closely 
linked to the metabolic demands of the parasite. The 
ability of T. gondii to metabolically adapt to a heme-
deficient lifestyle, albeit limited, highlights the 
metabolic flexibility exhibited by these parasites 
which is echoed in the decreased heme levels found 
in the drug resistant Plasmodium kelch13 mutants. 
Heme, either produced de novo or scavenged from 
the host, is key to the susceptibility of apicomplexans 
to artemisinins. Modulating heme levels within the 
parasite, possibly through partner drugs, presents 
an intriguing opportunity for synergistic anti-malarial 
treatments.  
Several questions concerning the synthesis and 
intracellular roles of heme remain. Transporters of 
porphyrin intermediates must be identified and 
characterized to better understand flux through the 
pathway. In many other organisms, heme production 
is regulated at multiple levels as excess heme is 
toxic. Regulation of metabolic processes has been 
understudied in the Apicomplexa; however, the 
relatively simple, unidirectional heme biosynthesis 
pathway may be amenable to such investigation. 
The role of heme itself as a signaling molecule has 
been examined in other organisms [3-5] and the 
abundance of labile heme in Apicomplexa may make 
this an interesting avenue for further research. 
Identification of uncharacterized transporters and 
discovery of divergent regulatory mechanisms in 
Apicomplexa is expected to reveal novel candidate 
targets for intervention and help unravel the mode of 
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